Physician profile
Jorge Galan
NPI 1598746612
$13,486.71
in general payments reported to CMS, 2019-2025
44 companies · $1,618 in 2025
The $1,618 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,437 · 2020: $1,237 · 2021: $2,637 · 2022: $2,503 · 2023: $2,176 · 2024: $1,879 · 2025: $1,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,650 · Education: $22.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,650.07 |
| Education | $22.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,211.84 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,051.57 | 2019-2025 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $1,069.69 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Pfizer INC. | $629.43 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $617.63 | 2019-2025 | Entyvio |
| Celgene Corporation | $585.01 | 2021-2024 | Zeposia |
| Qol Medical, LLC | $583.57 | 2021-2025 | Sucraid, Sucraid |
| Gilead Sciences, INC. | $552.23 | 2020-2023 | |
| Genzyme Corporation | $353.99 | 2022-2025 | |
| Ironwood Pharmaceuticals, INC | $240.57 | 2019-2023 | Linzess |
| Nestle Healthcare Nutrition INC. | $209.54 | 2020-2023 | |
| Regeneron Healthcare Solutions, INC. | $207.85 | 2022-2025 | Dupixent |
| Ferring Pharmaceuticals INC. | $199.66 | 2019-2025 | Rebyota |
| Intercept Pharmaceuticals, INC. | $175.23 | 2019-2024 | |
| Fresenius Kabi USA, LLC | $171.84 | 2023-2024 | Idacio |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Galan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.